Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein

✍ Scribed by Yasuhiro Itsui; Naoya Sakamoto; Sei Kakinuma; Mina Nakagawa; Yuko Sekine-Osajima; Megumi Tasaka-Fujita; Yuki Nishimura-Sakurai; Gouki Suda; Yuko Karakama; Kako Mishima; Machi Yamamoto; Takako Watanabe; Mayumi Ueyama; Yusuke Funaoka; Seishin Azuma; Mamoru Watanabe

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 807 KB
• Volume: 50
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1002/hep.23195

✦ Synopsis

Interferons (IFNs) and the interferon-stimulated genes (ISGs) play a central role in antiviral responses against hepatitis C virus (HCV) infection. We have reported previously that ISGs, including guanylate binding protein 1 (GBP-1), interferon alpha inducible protein (IFI)-6-16, and IFI-27, inhibit HCV subgenomic replication. In this study we investigated the effects of these ISGs against HCV in cell culture and their direct molecular interaction with viral proteins. HCV replication and virus production were suppressed significantly by overexpression of GBP-1, IFI-6-16, or IFI-27. Knockdown of the individual ISGs enhanced HCV RNA replication markedly. A two-hybrid panel of molecular interaction of the ISGs with HCV proteins showed that GBP-1 bound HCV-NS5B directly. A protein truncation assay showed that the guanine binding domain of GBP-1 and the finger domain of NS5B were involved in the interaction. Binding of NS5B with GBP-1 inhibited its guanosine triphosphatase GTPase activity, which is essential for its antiviral effect. Taken together, interferon-induced GBP-1 showed antiviral activity against HCV replication.

Conclusion:

Binding of the hcv-ns5b protein to gbp-1 countered the antiviral effect by inhibition of its gtpase activity. these mechanisms may contribute to resistance to innate, ifn-mediated antiviral defense and to the clinical persistence of hcv infection.